Frontiers in Oncology, 2234-943X

Journal

More filtering options
  1. 2019
  2. 2018
  3. 2017
  4. Involvement of chromatin remodeling genes and the Rho GTPases RhoB and CDC42 in ovarian clear cell carcinoma

    Nicolai Skovbjerg Arildsen, Jenny Maria Jönsson, Bartuma, K., Anna Ebbesson, Westbom-Fremer, S., Måsbäck, A., Malander, S., Mef Nilbert & Ingrid A. Hedenfalk, 2017 May 29, In : Frontiers in Oncology. 7, MAY, p. 1-11 109.

    Research output: Contribution to journalArticle

  5. Targeting prostate cancer stem cells with alpha-particle therapy

    Elgqvist, J. & Jens Ceder, 2017 Jan 9, In : Frontiers in Oncology. 6, 11 p., 273.

    Research output: Contribution to journalArticle

  6. 2016
  7. MLH1 Ile219Val polymorphism in argentinean families with suspected lynch syndrome

    Dominguez-Valentin, M., Wernhoff, P., Cajal, A. R., Kalfayan, P. G., Piñero, T. A., Gonzalez, M. L., Ferro, A., Sammartino, I., Causada Calo, N. S. & Vaccaro, C. A., 2016 Aug 24, In : Frontiers in Oncology. 6, AUG, 189.

    Research output: Contribution to journalArticle

  8. Editorial: Novel targets and targeting technologies to modulate tumor microenvironment

    Prakash, J. (ed.) & Kristian Pietras (ed.), 2016, In : Frontiers in Oncology. 6, MAY, 121.

    Research output: Contribution to journalSpecial Issue (editor)

  9. 2012
  10. Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions.

    Tang, M-H. E., Varadan, V., Kamalakaran, S., Zhang, M. Q., Dimitrova, N. & Hicks, J., 2012, In : Frontiers in Oncology. 2, Dec.,27, p. 197

    Research output: Contribution to journalArticle